PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
Data generation and assessment | ARN | Regulatory risk management | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1-isopropyl-1H-pyrazole | 823-314-7 | 18952-87-9 | - | - | - | - | 1 | - | - | - | - | Details |
1-isopropyl-2,2-dimethyltrimethylene diisobutyrate | 229-934-9 | 6846-50-0 | - | - | 5 | - | - | - | - | - | - | Details |
1-isopropyl-4-methylcyclohexane | 202-790-4 | 99-82-1 | - | - | 2 | - | - | - | - | - | - | Details |
1-methoxyhexane | 225-263-0 | 4747-07-3 | - | - | 1 | - | - | - | - | - | - | Details |
1-methyl-2-pyrrolidone | 212-828-1 | 872-50-4 | - | - | - | - | 1 | 1 | 1 | 1 | 1 | Details |
1-Methyl-3-nitro-guanidine | 433-400-2 | - | - | - | - | - | 1 | - | - | - | - | Details |
1-Methyl-3-nitroguanidine | 610-029-6 | 4245-76-5 | - | - | - | - | 1 | - | - | - | - | Details |
1-methyl-3-phenylpropylamine | 244-942-2 | 22374-89-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
1-methylheptyl acrylate | 256-005-5 | 42928-85-8 | - | - | - | - | 1 | - | - | - | - | Details |
1-methylimidazole | 210-484-7 | 616-47-7 | - | - | 3 | - | 1 | - | - | - | - | Details |
1-methylpiperazine | 203-639-5 | 109-01-3 | - | - | 1 | - | 1 | - | - | - | - | Details |
1-methyltrimethylene dimethacrylate | 214-711-0 | 1189-08-8 | - | - | 1 | - | 1 | - | - | - | - | Details |
1-Naphthalenamine, 1,2,3,4-tetrahydro-, (1R)- | 628-771-4 | 23357-46-2 | - | - | - | - | 1 | - | - | - | - | Details |
1-Naphthalenamine, 1,2,3,4-tetrahydro-, (1S)- | 629-348-7 | 23357-52-0 | - | - | - | - | 1 | - | - | - | - | Details |
1-Naphthalenemethanamine, a-methyl- | 610-076-2 | 42882-31-5 | - | - | - | - | 1 | - | - | - | - | Details |
1-naphthylacetonitrile | 205-078-1 | 132-75-2 | - | - | - | - | 1 | - | - | - | - | Details |
1-nitrobutane | 210-980-3 | 627-05-4 | - | - | - | - | 1 | - | - | - | - | Details |
1-NITROCYCLOHEPTANE | 659-779-6 | 2562-40-5 | - | - | - | - | 1 | - | - | - | - | Details |
1-nitroguanidine | 209-143-5 | 556-88-7 | - | - | 2 | - | 1 | - | - | - | - | Details |
1-nitrohexane | 211-467-7 | 646-14-0 | - | - | - | - | 1 | - | - | - | - | Details |
1-NITROOCTANE | 659-737-7 | 629-37-8 | - | - | - | - | 1 | - | - | - | - | Details |
1-nitropentane | 211-025-3 | 628-05-7 | - | - | - | - | 1 | - | - | - | - | Details |
1-nitropropane | 203-544-9 | 108-03-2 | - | - | 1 | - | 1 | 1 | - | - | - | Details |
1-o-tolylbiguanide | 202-268-6 | 93-69-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
1-Octadecanaminium, N,N-dimethyl-N-octadecyl-, (SP-4-2)-[29H,31H-phthalocyanine-2-sulfonato(3-)-[?]N29,[?]N30,[?]N31,[?]N32]cuprate(1-) (1:1) | 404-170-0 | 70750-63-9 | - | - | 1 | - | - | - | - | - | - | Details |
EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.